SAN FRANCISCO/CHICAGO (Reuters) - Russell Wasendorf Jr., whose father went to prison for stealing $215 million from clients of the futures brokerage they ran together for nearly 20 years, is starting over.
Peregrine Pharmaceuticals (PPHM)
Q3 2013 Earnings Call
March 12, 2013 4:30 pm ET
Executives
Jay Carlson
Steven W. King - Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Joseph S. Shan - Vice President of Clinical & Regulatory Affairs
Robert Garnick - Head of Regulatory Affairs
Peregrine Pharmaceuticals (PPHM)
Q3 2011 Earnings Call
March 11, 2011 4:30 pm ET
Executives
Joseph Shan - Vice President of Clinical & Regulatory Affairs
Steven King - Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Peregrine Pharmaceuticals (PPHM)
Q1 2013 Earnings Call
September 10, 2012 11:00 am ET
Executives
Jay Carlson
Steven W. King - Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Joseph S. Shan - Vice President of Clinical & Regulatory Affairs
Robert Garnick - Head of Regulatory Affairs
Peregrine Pharmaceuticals (PPHM)
Q4 2012 Earnings Call
July 16, 2012 4:30 pm ET
Executives
Jay Carlson
Steven W. King - Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Joseph S. Shan - Vice President of Clinical & Regulatory Affairs
Peregrine Pharmaceuticals (PPHM)
Q2 2012 Earnings Call
December 12, 2011 4:30 pm ET
Executives
Steven W. King - Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Paul J. Lytle - Chief Financial Officer, Principal Accounting Officer, Corporate Secretary, Chief Financial Officer of Avid Bioservices and Corporate Secretary of Avid Bioservices
Peregrine Pharmaceuticals (PPHM)
Q1 2012 Earnings Call
September 09, 2011 11:30 am ET
Executives
Unknown Speaker -
Robert Garnick - Head of Regulatory Affairs
Steven King - Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Peregrine Pharmaceuticals (PPHM)
Q4 2011 Earnings Call
July 14, 2011 4:30 pm ET
Executives
Unknown Speaker -
Robert Garnick - Head of Regulatory Affairs
Joseph Shan - Vice President of Clinical & Regulatory Affairs
Steven King - Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc